Cargando…
Anticonvulsant drugs in bipolar disorder
Although much progress has been made in successfully treating bipolar disorder, there is increasing awareness of the limitations of traditional treatment regimens such as lithium and neuroleptics. The large family of anticonvulsant drugs, however, appears to be capable of providing new treatment opt...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181564/ https://www.ncbi.nlm.nih.gov/pubmed/22033602 |
_version_ | 1782212761962414080 |
---|---|
author | Grunze, Heinz Schlösser, Sandra Amann, Benedikt Walden, Jörg |
author_facet | Grunze, Heinz Schlösser, Sandra Amann, Benedikt Walden, Jörg |
author_sort | Grunze, Heinz |
collection | PubMed |
description | Although much progress has been made in successfully treating bipolar disorder, there is increasing awareness of the limitations of traditional treatment regimens such as lithium and neuroleptics. The large family of anticonvulsant drugs, however, appears to be capable of providing new treatment options, not only as medication of second choice in patients refractory to treatment, but often as a treatment standard with high efficacy and low incidence of side effects. Besides established mood stabilizers such as carbamazepine and valproate, new antiepileptic drugs are entering the field with promising initial results in the treatment of bipolar patients. Furthermore, bringing to light the mechanisms of action of anticonvulsants and the similarities between anticonvulsants effective in bipolar disorder may also deepen our understanding of the pathophysiological basis of the disorder. |
format | Online Article Text |
id | pubmed-3181564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1999 |
publisher | Les Laboratoires Servier |
record_format | MEDLINE/PubMed |
spelling | pubmed-31815642011-10-27 Anticonvulsant drugs in bipolar disorder Grunze, Heinz Schlösser, Sandra Amann, Benedikt Walden, Jörg Dialogues Clin Neurosci Clinical Research Although much progress has been made in successfully treating bipolar disorder, there is increasing awareness of the limitations of traditional treatment regimens such as lithium and neuroleptics. The large family of anticonvulsant drugs, however, appears to be capable of providing new treatment options, not only as medication of second choice in patients refractory to treatment, but often as a treatment standard with high efficacy and low incidence of side effects. Besides established mood stabilizers such as carbamazepine and valproate, new antiepileptic drugs are entering the field with promising initial results in the treatment of bipolar patients. Furthermore, bringing to light the mechanisms of action of anticonvulsants and the similarities between anticonvulsants effective in bipolar disorder may also deepen our understanding of the pathophysiological basis of the disorder. Les Laboratoires Servier 1999-06 /pmc/articles/PMC3181564/ /pubmed/22033602 Text en http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Research Grunze, Heinz Schlösser, Sandra Amann, Benedikt Walden, Jörg Anticonvulsant drugs in bipolar disorder |
title | Anticonvulsant drugs in bipolar disorder |
title_full | Anticonvulsant drugs in bipolar disorder |
title_fullStr | Anticonvulsant drugs in bipolar disorder |
title_full_unstemmed | Anticonvulsant drugs in bipolar disorder |
title_short | Anticonvulsant drugs in bipolar disorder |
title_sort | anticonvulsant drugs in bipolar disorder |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181564/ https://www.ncbi.nlm.nih.gov/pubmed/22033602 |
work_keys_str_mv | AT grunzeheinz anticonvulsantdrugsinbipolardisorder AT schlossersandra anticonvulsantdrugsinbipolardisorder AT amannbenedikt anticonvulsantdrugsinbipolardisorder AT waldenjorg anticonvulsantdrugsinbipolardisorder |